Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11883-014-0459-4 http://scihub22266oqcxt.onion/10.1007/s11883-014-0459-4 C4819243!4819243!25301353     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25301353.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Curr+Atheroscler+Rep 2014 ; 16 (12): 459 Nephropedia Template TP {{tp|p=25301353|t=2014. Endovascular Versus Medical Therapy for Atherosclerotic Renovascular Disease |pdf=|usr=}}{{25301353}} gab.com Text Endovascular Versus Medical Therapy for Atherosclerotic Renovascular Disease JO: Curr Atheroscler Rep http://www.kidney.de/pget.php?&tw=1&pmid=25301353 #FOAvip The diagnosis of renal artery stenosis (RAS) has become increasingly common in part due to greater awareness of ischemic renal disease and increased use of diagnostic techniques. Over 90 % of RAS cases are caused by atherosclerotic renovascular disease (ARVD). Patients with ARVD are at high risk for fatal and nonfatal cardiovascular and renal events. The mortality rate in patients with ARVD is high, especially with other cardiovascular or renal comorbidities. Recent clinical studies have provided substantial evidence concerning medical therapy and endovascular interventional therapeutic approaches for ARVD. Despite previous randomized clinical trials, the optimal therapy for ARVD remained uncertain until the results of the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) trial were released recently. CORAL demonstrated that optimal medical therapy was equally effective to endovascular therapy in the treatment of ARVD. Clinicians can now practice with more evidence-based medicine to treat ARVD and potentially decrease mortality in patients with ARVD using optimal medical therapy. Twit Text FOAVip Endovascular Versus Medical Therapy for Atherosclerotic Renovascular Disease ????Curr Atheroscler Rep http://www.kidney.de/pget.php?&tw=1&pmid=25301353 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25301353 #FOAvip English Wikipedia <ref>{{Cite pmid|25301353}}</ref> Endovascular Versus Medical Therapy for Atherosclerotic Renovascular Disease #MMPMID25301353 Yu MS; Folt DA; Drummond CA; Haller ST; Cooper EL; Brewster P; Evans KL; Cooper CJ Curr Atheroscler Rep 2014[Dec]; 16 (12): 459 PMID25301353show ga The diagnosis of renal artery stenosis (RAS) has become increasingly common in part due to greater awareness of ischemic renal disease and increased use of diagnostic techniques. Over 90 % of RAS cases are caused by atherosclerotic renovascular disease (ARVD). Patients with ARVD are at high risk for fatal and nonfatal cardiovascular and renal events. The mortality rate in patients with ARVD is high, especially with other cardiovascular or renal comorbidities. Recent clinical studies have provided substantial evidence concerning medical therapy and endovascular interventional therapeutic approaches for ARVD. Despite previous randomized clinical trials, the optimal therapy for ARVD remained uncertain until the results of the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) trial were released recently. CORAL demonstrated that optimal medical therapy was equally effective to endovascular therapy in the treatment of ARVD. Clinicians can now practice with more evidence-based medicine to treat ARVD and potentially decrease mortality in patients with ARVD using optimal medical therapy. äEndovascular Versus Medical Therapy for Atherosclerotic Renovascular D(epmc).pdf DeepDyve Pubget Overpricing